Picture [LSUS] – The Business Web Portal 600x60px
Organisation › Details

AB2 Bio Ltd. (CH)

AB2 Bio Ltd., located at the Innovation Park of the École Polytechnique Fédérale de Lausanne (EPFL), is a drug discovery and development company focused on developing “best in class” innovative therapies for the treatment of inflammatory diseases with large unmet medical needs. Inflammation is a natural defense mechanism. However, dysregulated and persistent inflammatory processes are the basis of several chronic inflammatory and autoimmune diseases, such as: NLRC4 - MAS, Adult onset Still's Disease, Chronic Obstructive Pulmonary Disease and many others. AB2 Bio is developing drugs that will not only treat the symptoms but also target the underlying causes of inflammation-based diseases. Extensive Phase I and Ib clinical trials demonstrated a high tolerance and an excellent safety profile of our drug. We have advanced clinical programs in NLRC4 – MAS and in Adult onset Still’s Disease. *


Period Start 2010-01-01 established
Products Industry tadekinig alfa (IL-18BP – Interleukin-18 Binding Protein)
  Industry 2 drug development
Persons Person Sleight, Andrew (AB2 Bio 201602 CEO before 21y at Roche)
  Person 2 Cunha, Fernando (AB2 Bio 201602 CFO)
Region Region Lausanne VD
  Country Switzerland
  Street EPFL Innovation Park
EPFL Innovation Park, Bldg. B, 4th Floor
  City 1015 Lausanne VD
  Tel +41-21-693-8280
    Address record changed: 2018-07-24
Basic data Employees n. a.
    �About Section� taken from web site of organisation on 22.02.
Record changed: 2017-04-01


Picture [LSA] – The Business Web Portal 650x89px

More documents for AB2 Bio Ltd. (CH)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top